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Results: Preliminary data show that the medial and lateral tibial plateaus
had signiﬁcant difference in subchondral bone parameters especially at
24 week of age. The medial plateaus showed an increase in BMD up
to 30 weeks and increases in SbpTh and trabecular thickness (TbTh)
up to week 24. These parameters were signiﬁcantly higher in the
medial compared to the lateral site (BMD, P< 0.05; SbpTh, P < 0.001;
TbTh, P < 0.05). The lateral plateau, showed a signiﬁcant increase in
bone volume/tissue volume (BV/TV) (P < 0.05), trabecular bone number
(TbN) (P < 0.01) and a signiﬁcant decrease in trabecular bone pattern
factor (TbPf) (P < 0.001) between 16 and 24 weeks. Of all the bone
parameters, only TbN (P < 0.05) was signiﬁcantly higher in the lateral
plateau while trabecular bone separation (TbSp) was signiﬁcantly lower
(P < 0.001), compared to the medial plateau. Macroscopic scores did not
show any signiﬁcant changes over the study period. But, microscopic
grading showed mild to moderate cartilage damage which was higher
in the medial than the lateral plateaus. There were some association
between the severity of cartilage degeneration and subchondral bone
changes tibial plateau.
Conclusions: Our preliminary data showing a signiﬁcant increase in
subchondral bone plate thickness in the medial compared to the lateral
plateau support the theory that subchondral bone plate thickness in
the medial site precedes changes in the lateral site in early OA.
The subchondral plate thickening may be viewed as an attempt to
compensate over compromised structural trabecular parameters and
hence preserve mechanical properties, while the thicker trabecular bone
may strengthen and compensate for the lack of connectivity found in
the medial as compared to the lateral plateau.
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THE DIFFERENTIATION OF CARTILAGE CHANGES AFTER ANTERIOR
CRUCIATE LIGAMENT TRANSECTION AMONG RABBITS OF DISTINCT
AGES
Q. Jiang, M. Chu, L. Sun, D. Shi. Ctr. of Diagnosis and Treatment for joint
disease, Nanjing, China
Purpose: In order to understand more about anterior cruciate ligament
(ACL) injury and help dealing with ACL injury patients of different ages,
we studied cartilage changes after ACL transection among rabbits of
distinct ages.
Methods: In total, 30 rabbits comprising 3 age groups (A: 6 months,
B: 12 months, C: 24 months, n = 10) were used for analysis. Each group
was randomly divided into 5 groups (n =2). Rabbits’ right knees received
ACL transaction, and the left knees were treated as control. Rabbits were
sacriﬁced at the time of 5, 10, 15, 20 and 25 weeks after operation. We
performed histological study (masson staining) for both knees of each
rabbit and measured cartilage water ratio (WR) and gross injury score.
Results: We found that cartilage of the right knees degenerated more
seriously than that of the left knees, and the cartilage of right knees
degenerated fastest in group B while slowest in group C by macroscopic
observation and masson staining. At 25 weeks after ACL transection,
the cartilage degeneration was slightest in the rabbits of group C, more
serious in group A, most serious in group B (Figure 1). There was a
trend that the cartilage WR was increased and then decreased with the
development of cartilage degeneration.
Conclusions: The signiﬁcant different cartilage changes among distinct
age groups suggest that the early intervention is necessary when dealing
with young and middlescent ACL injury patients, but for old patients we
may choose conservative treatment.
Fig. 1. Masson staining, 25 weeks after operation. (a) Group A;
(b) Group B; (c) Group C.
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SIMULTANEOUS TARGETING OF IL-1A AND IL-1B BY A DUAL-VARIABLE-
DOMAIN IMMUNOGLOBULIN (DVD-IG™) PREVENTS CARTILAGE
DEGRADATION IN PRECLINICAL MODELS OF OSTEOARTHRITIS
R.V. Kamath, M. Hart, D. Conlon, T. Ghayur. Abbott Labs, Worcester, MA,
USA
Purpose: Interleukin-1 (IL-1) plays a major role in the development
and progression of osteoarthritis (OA). IL-1a and IL-1b are two distinct
cytokines that bind to the same receptor and are expressed in synovial
membranes, cartilage, and synovial ﬂuid of patients with OA. IL-1 induces
structural changes (cartilage degradation, bone sclerosis & synovial
proliferation) by inducing proteases and proinﬂammatory cytokines from
all tissues (cartilage, bone and synovium) of the joint. The purpose of
the study is to demonstrate a) blockade of both IL-1a and IL-1b with
a combination of anti-mouse IL-1a and IL-1b monocloncal antibodies
(mAbs) is efﬁcacious compared to treatment with single mAbs in mouse
models of OA, and b) to demonstrate that anti-IL-1a/b dual variable
domain-Ig (DVD-Ig) produces similar efﬁcacy as the combination of
anti-mouse IL-1a and IL-1b mAbs.
Methods: Interleukin-1 (IL-1) plays a major role in the development
and progression of osteoarthritis (OA). IL-1a and IL-1b are two distinct
cytokines that bind to the same receptor and are expressed in synovial
membranes, cartilage, and synovial ﬂuid of patients with OA. IL-1 induces
structural changes (cartilage degradation, bone sclerosis & synovial
proliferation) by inducing proteases and proinﬂammatory cytokines from
all tissues (cartilage, bone and synovium) of the joint. The purpose of
the study is to demonstrate a) blockade of both IL-1a and IL-1b with
a combination of anti-mouse IL-1a and IL-1b monocloncal antibodies
(mAbs) is efﬁcacious compared to treatment with single mAbs in mouse
models of OA, and b) to demonstrate that anti-IL-1a/b dual variable
domain-Ig (DVD-Ig) produces similar efﬁcacy as the combination of
anti-mouse IL-1a and IL-1b mAbs.
Results: In both JIM and DMM model, cartilage degeneration in animals
treated with either anti-IL-1a (6mg/kg) or IL-1b mAbs (6mg/kg) was
similar to vehicle control knees. However, a combination therapy
with both antibodies (6mg/kg each signiﬁcantly decreased cartilage
degeneration scores. We have recently reported on a novel dual-
speciﬁc biologics approach, termed DVD-Ig™ that can convert two pre-
existing mAbs into a dual targeting agent by combining the variable
domains of two mAbs via naturally occurring linkers. Anti-mIL-1a/b
DVD-Ig (6mg/kg) also signiﬁcantly inhibited the progression of OA with
comparable efﬁcacy to the combination of the parental mAbs.
Conclusions: Our preclinical data demonstrate that combination of
mouse anti-mouse-IL-1a and anti-mouse-IL-1b mAb as well as anti-
mouse-IL-1a/b DVD-Ig™ molecules had signiﬁcant beneﬁcial effects on
histopathological parameters of mouse OA. These preclinical proof of
concept studies with anti-IL-1a/b DVD-Ig™ molecules form the basis
for further investigation of therapeutic IL-1a/b DVD-Ig™ molecules in
human OA patients.
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THE TYPE III COLLAGEN TURNOVER AND NITROSYLATION IN A RAT
MODEL OF COLLAGEN INDUCED ARTHRITIS (CIA). APPLYING THREE
NOVEL ELISA’S MEASURING TYPE III COLLAGEN NEOEPITOPES
A.S. Gottrup1, J. Wang2, Q. Liu2, Q. Zheng2, P. Qvist1, M.A. Karsdal1,
A-C. Bay-Jensen1. 1Nordic BioSci. A/S, Herlev, Denmark; 2Nordic BioSci.
China, Beijing, China
Purpose: The chronic inﬂammatory disease, rheumatoid arthritis,
primarily affects the synovial joints. Thickening of the synovial
membrane is the main consequences of the inﬂammation, but alterations
are also detected in cartilage and bone. During inﬂammation, nitric oxide
levels are elevated resulting in increased post-translational modiﬁcation
of extracellular proteins, such as nitrosylation of tyrosines. Thickening
of the synovial membrane, which is caused by increased cell numbers,
lead to elevated levels of proteolytic enzymes. This lead to increased
degradation of the surrounding tissue, increasing the turnover of
extracellular matrix, e.g. type III collagen. In this experiment we
investigated whether nitrosylation of tyrosine of the synovial membrane
is dependent of the turnover of the tissue (detected as type III collagen
turnover).
Methods: Collagen induced arthritis (CIA) was induced in 10 Wistar rats
by immunizations with 450ml 2mg/ml porcine type II collagen dissolved
in 0.05M acetic acid and emulsiﬁed 1:1 in Incomplete Freunds Adjuvant
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on day 0 and 7. 10 Wistar rats were used as control, with injection of
0.05M acetic acid. On day 16 all 10 CIA rats were diseased, determined
by swollen paws. All the rats were scariﬁed at day 26. Blood was taken
at baseline, during the experiment and at termination and used for
biomarkers measurements. Disease onset was deﬁned as the day with
signiﬁcant difference between the paw score (swelling of paws) of SHAM
and CIA. ELISAs were used to quantitatively measure turnover of type III
collagen, CO3–610 to detect degradation and PIIINP to detect formation.
A novel competitive ELISA (s-NysCo3) was used to detect nitrosylation
of mature type III collagen.
Results: A 40% increase in degradation of type III collagen was detected
in CIA rats after disease onset, but no signiﬁcant increase in formation
of type III collagen was detected. However, there was a tendency of
increased formation of type III collagen in CIA rats after disease onset.
These results led to a 40% increase of type III collagen turnover in the
diseased CIA rats and this increase of turnover was already, though not
signiﬁcant, detected at day 7. The nitrosylation of mature type III collagen
was detected with at novel competitive ELISA, showing a tendency of
increased nitrosylation of type III collagen in CIA rats after disease onset.
However, when comparing the amount of nitrosylation to the amount of
degraded type III collagen, a decrease in nitrosylation of type III collagen
was detected.
Conclusions: Collagen induced arthritis in rats increased type III collagen
turnover after disease onset and the level of nitrosylation of tyrosines
was elevated compared to SHAM. However, the level of nitrosylation in
CIA rats compared to the turnover of type III collagen showed lower a
nitrosylation rate. This could be a direct effect of the increased amount
of degradation of type III collagen in the CIA rats. In conclusion, the level
nitrosylation of type III collagen is depended of the turnover of type III
collagen.
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INHIBITION OF TRANSFORMING GROWTH FACTOR ALPHA SIGNALING
SLOWS PROGRESSION OF OSTEOARTHRITIS
S.E. Usmani, T.C. Appleton, V. Ulici, I.D. Welch, T.L. Hill, F. Beier. The Univ.
of Western Ontario, London, ON, Canada
Purpose: No cures currently exist for the degenerative joint disease
osteoarthritis (OA). Furthermore, the complex and multi-variable nature
of OA continues to challenge the development of effective therapies. In an
attempt to identify potential targets for disease modifying osteoarthritis
drugs (DMOADs), our lab recently established a surgical model of OA to
study gene expression changes in degenerating cartilage. Transforming
growth factor alpha (TGFa) gene expression was upregulated in our
model and further in vitro studies showed that TGFa suppressed
chondrocyte expression of anabolic factors aggrecan and type II collagen
and increased expression of the catabolic factor matrix metalloproteinase
13 (MMP13). We thus identiﬁed TGFa as a novel therapeutic OA target.
The purpose of this project is to examine the role of TGFa in the
development of OA in vivo. We hypothesize that inhibition of TGFa
signaling will delay disease progression in surgical OA models.
Methods: Adult male Tgfa null mice and control littermates received
either meniscotibial transection (MTX) or sham surgery. At 7 and
14 weeks post-surgery knee joint histopathology was assessed using
the OARSI scoring method and tissues were immunostained for disease
markers such as MMP13 and type II collagen neoepitopes. Since
some features of cartilage and bone development are known to be
recapitulated during the disease process, skeletal development in Tgfa
null mice was also examined.
Results: MTX surgery produced mild and moderate OA in mice after 7
and 14 weeks. Tgfa null mice had lower OARSI scores and expressed less
MMP13 and type II collagen neoepitopes than their control littermates.
Tgfa null mice also showed transient growth retardation after birth.
Histological analyses demonstrated a wider hypertrophic zone of the
growth plate. TRAP staining showed a decrease in osteoclasts at
the cartilage-bone interface, suggesting that removal of hypertrophic
cartilage is delayed. These phenotypes are absent in adult mice.
Conclusions: TGFa signaling plays an important role in osteoarthritis
progression in vivo and should be investigated further as a potential
target for DMOAD development.
129
CORRELATION OF PAIN AND STRUCTURAL DAMAGES IN RAT MIA
MODEL
L. Song1, A. Bendele2, S. Coyle1, R. Zhang1, J.P. Spalazzi1, T. Davisson1.
1Stryker Orthopaedics, Mahwah, NJ, USA; 2Bolder BioPATH Inc., Boulder, CO,
USA
Purpose: Intra-articular injection of monoiodoacetate (MIA) in the
rodent joint can cause chondrocyte death and subsequent cartilage
degeneration. It can also lead to subchondral bone degradation and
gait alteration. Therefore it is considered a useful osteoarthritis model to
evaluate pharmaceutical and biologic agents to inhibit cartilage and bone
degeneration and alleviate pain. The severity of pain/gait alteration and
structural damage depend on MIA concentration and injection frequency.
However it is unknown if there is any correlation between pain and
structural damage over time. This study investigates how the pain/gait
change correlates with structural damages longitudinally at two MIA
doses in rat. It was hypothesized that the gait and structural changes
would exhibit a similar trend during the post-MIA injection period.
Methods: Two groups of Sprague Dawley rats (n = 12/group) were
injected with 0.5mg or 2mg of MIA (40ml) on day 0 on their right knees.
Gait analysis, incapacitance testing, and knee diameter measurement
were performed before MIA injection and on days 3, 7, 14, 21, 28, and
35 days post-injection. Animals were sacriﬁced on days 21 (n =4) and 35
(n =8) for microCT and histopathologic evaluation. For microCT, the right
knee from each animal was scanned at a norminal resolution of 18mm
using Scanco mCT80. Bone volume of distal condyles was determined.
For histopathology, the right knees were trimmed into two equal frontal
halves, ﬁxed, decalciﬁed, embedded in parafﬁn and sectioned. Sctions
were stained with toluidine blue and examined microscopically. Cartilage
matrix damage, bone resorption, bone sclerosis and osteophyte were
scored for each sample. All data were expressed as Mean±SD. Two-way
ANOVA and post-hoc Tukey’s HSD testing or non-parametric testing were
performed with P < 0.05 considered signiﬁcant.
Fig. 1. Deﬁciency of right to total hindleg weight distribution by
incapacitance test.
Fig. 2. Representative microCT images of distal femur.
